UEC › analyze
UEC · Analyze
Date: 2026-06-10 | Price: $9.42 (Jun 10 close) / $10.445 (Jun 11 intraday) | 52wk Range: $5.90 – $20.34 | Market Cap: ~$5.1B (Jun 11) | Sector: Energy / Uranium (ISR Mining)
Manager Dispatch Summary
Full 4-phase pipeline executed. UEC is a pre-profitability ISR uranium miner at an inflection point — Burke Hollow just commenced production, UR&C conversion facility received its first NRC license milestone, and balance sheet is fortress-class ($794M liquid, zero debt). The stock is down 54% from January 2026 highs, well inside reasonable entry range. Standard DCF/Graham metrics do not apply — valuation is asset-based / option value. Verdict: [6.5/10] Speculative Buy at $8.50–10.50. Companion screen for nuclear pipeline opportunities attached in Discovery.
Phase 1 — Fundamentals Analyst
Revenue & Income (Fiscal Year ends July 31)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $23.2M | $164.4M | $0.2M | $66.8M |
| Gross Profit | $7.3M | $49.7M | $37K | $24.5M |
| Gross Margin | 31.5% | 30.2% | 16.5% | 36.6% |
| Operating Income | -$18.9M | +$9.1M | -$56.6M | -$73.4M |
| Net Income | +$5.3M | -$3.3M | -$29.2M | -$87.7M |
| Diluted EPS | +$0.02 | -$0.01 | -$0.07 | -$0.20 |
Revenue interpretation: ISR uranium miners don't sell production continuously. They accumulate inventory and sell in blocks when spot prices are favorable. FY2023 ($164M) reflects a bulk strategic sale at elevated prices; FY2024 ($0.2M) reflects deliberate withholding to rebuild inventory at lower cost. FY2025 ($66.8M) is partial normalization. Do not read these numbers as trend lines — they are not.
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating CF | -$53.0M | +$72.6M | -$106.5M | -$64.5M |
| CapEx | -$1.2M | -$0.7M | -$3.4M | -$5.7M |
| Free Cash Flow | -$54.2M | +$71.9M | -$109.9M | -$70.2M |
| Equity Raised | +$168M | +$66.5M | +$176.7M | +$287.5M |
| Investing CF | -$110.8M | -$124.8M | -$24.6M | -$157.0M |
FCF CAGR: Not computable. Pattern is "raise equity → acquire assets → sell uranium inventory in favorable markets → repeat." This is a development-stage miner, not a compounder.
Capital allocation breakdown (FY2022–FY2025): - Asset acquisitions (mines, properties): ~$311M (60%) - Operating cash burn (G&A, working capital): ~$221M (43%) - CapEx (equipment): ~$11M (2%) - Zero dividends, zero buybacks, zero debt service
Balance Sheet (FY2025 end / Q3 FY2026 updated)
| Metric | FY2025 (Jul 31) | Q3 FY2026 (Apr 30) |
|---|---|---|
| Cash & Equivalents | $148.9M | $488M |
| Total Liquid Assets | — | $794M |
| Uranium Inventory | $79.3M (book) | $127M (market, 1.456M lbs) |
| Mineral Properties (Net PPE) | $777.2M | ~$800M+ |
| Total Assets | $1.107B | ~$1.2B+ |
| Total Financial Debt | $0 | $0 |
| Total Liabilities | $123.8M | ~$130M |
| Stockholders' Equity | $983.9M | ~$1.05B |
| Debt/Assets | 0% | 0% |
Zero debt. Exceptional for a mining company at this stage. The $794M in liquid assets provides ~2+ years of runway at the current ~$65M/year cash burn rate.
Shares Outstanding (Dilution Tracker)
| Date | Shares | Δ vs. FY2022 |
|---|---|---|
| FY2022 | 289.6M | — |
| FY2023 | 378.5M | +30.7% |
| FY2024 | 410.4M | +41.7% |
| FY2025 | 454.0M | +56.8% |
| Est. Jun 2026 | ~490M | ~+69% |
Dilution is the #1 fundamental risk. The company funds operations primarily through equity issuances. At this pace (~10-15% annual dilution), per-share value accretion requires uranium prices to rise substantially faster than dilution compounds. Watch share count growth every quarter.
Per-Share Metrics
| Metric | FY2025 | Q3 FY2026 est. |
|---|---|---|
| Book Value/Share | $2.17 | ~$2.14 |
| Cash + Liquidity/Share | ~$0.33 | ~$1.62 |
| Uranium Inventory/Share | $0.17 | ~$0.26 |
| Revenue/Share | $0.15 | — (lumpy) |
| FCF/Share | -$0.15 | — |
Phase 1 — Sentiment Analyst
Analyst Consensus
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| Current | 2 | 6 | 1 | 0 | 0 |
| -1 Month | 2 | 6 | 1 | 0 | 0 |
| -2 Month | 2 | 6 | 1 | 0 | 0 |
| -3 Month | 2 | 6 | 1 | 0 | 0 |
Consensus: 8 Buy / 2 Strong Buy / 1 Hold — overwhelmingly bullish, stable for 3+ months. No analysts have downgraded despite the 54% price decline from January highs. This signals analyst confidence in the thesis rather than short-term price momentum chasing.
Q3 FY2026 Earnings Summary (Quarter Ended April 30, 2026)
Operational milestones: - Burke Hollow commenced production — "America's largest greenfield ISR uranium project in more than 10 years." This is the third major production hub; now two of three planned U.S. hubs operational. - Christensen Ranch expanded: 3 new header houses installed, 5 more under construction. Accelerating production ramp. - UR&C conversion facility: Received first NRC licensing milestone — a Docket Number assigned. The clock on conversion facility licensing has officially started.
Key production & cost metrics: - Q3 production: 32,195 lbs U₃O₈ - Q3 total cost/lb: $54.61 | Cash cost/lb: $46.69 (elevated due to Burke Hollow startup; expected to decline as ramp matures) - Cumulative cost since FY2025: $39.30/lb (vs. uranium spot $86/lb → ~$47/lb gross margin at full production scale) - Total uranium inventory: 1,456,000 lbs valued at $127M market prices
Balance sheet (reiterated): $794M liquid, $0 debt. Management guided production and cost improvements in Q4 FY2026.
Policy & Market Catalysts
- Section 232 (January 2026): Uranium formally designated a U.S. national security asset. Opens door to price floors, import curbs on Russian/Kazakh uranium, and potential government equity stakes in domestic producers. Direct beneficiary: UEC (largest U.S. licensed ISR capacity).
- DOE "Nuclear Dominance — 3 by 33" initiative: Federal campaign targeting a secure domestic fuel supply chain by 2033, covering mining → milling → conversion → enrichment → recycling. UEC is at the front end of this chain.
- Urenco USA expansion (June 2, 2026): Urenco announced ~$8B enrichment capacity expansion (+50% by 2032). More enrichment downstream = more demand for U.S.-origin feedstock. Positive for UEC and LEU (already held).
- Uranium spot price: Peaked at $101.41/lb (Jan 29, 2026), now $86.10/lb (Jun 9, 2026). Long-term contract prices steady at $86-90/lb. The spot correction is the single biggest headwind for equity sentiment.
Insider & Institutional Activity
- CEO: Amir Adnani (Founder, long-tenured). No insider selling flagged in recent SEC filings.
- DEF 14A proxy filed June 5, 2026 (routine annual meeting).
- Institutional: Sprott Physical Uranium Trust continues accumulating physical uranium, providing ongoing demand support for spot.
- Sector momentum: Uranium mining equities up ~40% on average over past year despite muted spot prices — institutions are pricing in structural demand, not just commodity.
Price Action Context
The stock hit $20.34 in January 2026 then pulled back -54% to $9.42 today. This is a sector-wide derating, not UEC-specific — the entire uranium complex corrected as spot pulled from $101 to $86 and broader risk-off prevailed. UEC's correction is proportionally larger than spot's correction (~15%), suggesting dilution anxiety and early-stage production disappointment in the short-term. Sentiment bottom characteristics are present: flat analyst revisions, insider silence (not selling), continued institutional accumulation in physical.
Phase 2 — Moat Analyst
ROIC & Margin Trends
ROIC is not meaningful for an ISR miner in ramp-up phase. Gross margins on uranium sales (when they occur) run 30-37%, but G&A overhead ($22-27M/year) and development spending dominate the P&L. The relevant metric is cost per pound vs. spot price:
| Cost Measure | Value | Spot Margin |
|---|---|---|
| Cumulative production cost (since FY2025) | $39.30/lb | ~$47/lb at $86 spot |
| Q3 FY2026 all-in cost | $54.61/lb | ~$31/lb at $86 spot |
| UEC target at scale | ~$40-45/lb | ~$41-46/lb at $86 spot |
At steady-state (full production ramp), UEC is a high-margin uranium producer. The problem is "steady-state" is years away.
Moat Factors
Genuine moats:
-
Permitting barrier (strongest): UEC controls the largest licensed ISR production capacity in the U.S. (~12M lbs/year) across Wyoming and South Texas platforms. New uranium mine permits in the U.S. take 7-10+ years and face sustained environmental and regulatory opposition. This infrastructure cannot be replicated quickly, regardless of capital availability.
-
ISR technology expertise: In-situ recovery is 40-50% cheaper than conventional underground/open-pit mining. UEC has been executing ISR since 2004 — 20 years of operational knowledge with specific geological systems in Wyoming and South Texas. Knowhow matters.
-
Geographic concentration = operational efficiency: All production hubs are within UEC's historical operating geography. Incremental hubs share infrastructure, reducing marginal development cost.
-
Vertical integration pathway (nascent but strategic): If UR&C conversion facility is built, UEC will be the only company in the U.S. mining AND converting uranium. The conversion market is a ~$4B+ bottleneck with essentially no new domestic capacity. Post-Russian supply sanctions, conversion is the single most constrained step in the nuclear fuel cycle. UEC's UR&C conversion plant targets 5M lbs U₃O₈ equivalent per year. This is a multi-year regulatory and construction project, but if executed, it creates a structural pricing advantage: UEC would sell finished conversion product (UF₆) rather than raw yellowcake, at materially higher realized prices.
-
Policy moat ("America First" nuclear): Section 232, DOE "3×33" initiative, and bipartisan congressional support for domestic uranium production create an institutional buyer (U.S. government stockpile programs) and a protective regulatory environment. Kazatomprom cannot participate in U.S. DOE contract awards. This creates a captive, high-value demand source for domestic producers.
-
Zero debt: Competitors like Cameco carry significant debt. UEC's balance sheet purity allows it to weather uranium price cycles and opportunistically acquire assets during downturns (which is precisely what it has been doing since 2022).
Moat limitations:
-
Commodity product: Uranium is uranium. Utilities buy from lowest qualified cost-per-pound supplier, with U.S.-origin premiums capped by policy, not infinite. UEC cannot price at a massive premium to world market even with Section 232.
-
Global cost disadvantage: Kazatomprom mines at $10-15/lb. Cameco's McArthur River/Cigar Lake mines at ~$20-25/lb (highest-grade in world). UEC at $39-55/lb is competitive in a Section 232 domestic market but uncompetitive globally. UEC's viability is structurally dependent on a U.S.-domestic pricing structure or sustained spot prices above $70-75/lb.
-
Scale gap: 12M lb/year licensed capacity vs. ~130K lbs/year current production. Bridging this gap requires 5-10 years of capital spending, permitting, and operational execution. Every year of under-production is a year of dilutive equity funding.
-
Single commodity exposure: Unlike UUUU (rare earths) or BWXT (defense contracts), UEC is 100% correlated to uranium price. A $20/lb uranium price correction would materially impair the thesis.
Adversarial Stress Test
"How would a rational rival attack UEC's position?"
- Kazatomprom: Can flood the spot market at cost to punish domestic U.S. pricing. Did this from 2012-2020. Section 232 mitigates but doesn't eliminate this threat — they can still sell to U.S. utilities through intermediaries unless hard import quotas are enacted.
- Cameco: Is already competing for long-term contracts with superior grade assets. CCJ's McArthur River (18.7% grade U₃O₈) vs. UEC's ISR (average ISR grade ~0.05%) — cost structure comparison heavily favors CCJ on a global basis.
- Policy reversal: A future administration could deprioritize domestic uranium (as happened post-2012). Section 232 can be unwound.
- Conversion facility delays: UR&C is still in early NRC licensing. Class 4 cost study expected H1 2027. Construction is 5-7+ years away. This moat doesn't exist yet.
Evergreen Rating: 7/10
The permitting moat is real and durable (10+ year replication lag). The ISR expertise is real. The vertical integration pathway is strategically sound. However: moat quality is highly dependent on sustained U.S. policy support and uranium prices above $70/lb. This is not a capital-light compounder — it's a resource/extraction business with cyclical exposure and execution risk. Score reflects genuine competitive position within a constrained asset class, tempered by commodity and policy dependency.
Phase 2 — Valuation Analyst
Note: Standard models (Graham's Number, DDM, DYT, Bogle) do not apply. Graham requires positive EPS (EPS = -$0.20). DDM/DYT require dividends (none). Bogle requires meaningful earnings trajectory (not applicable for lumpy commodity miner). The correct framework is asset-based NAV + production option value.
NAV Calculation (Q3 FY2026 basis)
| Asset | Value | Notes |
|---|---|---|
| Cash + Short-term investments | $488M | Q3 balance sheet |
| Uranium inventory (market) | $127M | 1.456M lbs × $86/lb |
| Strategic equity investments | ~$56M | Long-term equity investments |
| Mineral properties (PP&E) | ~$800M | Book cost; likely understated at current uranium prices |
| Other assets | ~$40M | — |
| Gross Asset Value | ~$1.51B | |
| Deferred tax liabilities | -$62M | |
| Environmental provisions | -$39M | |
| Other liabilities | -$30M | |
| Net Asset Value | ~$1.38B | |
| Shares outstanding (est.) | ~490M | |
| NAV per share | ~$2.82/share |
Current P/NAV at $9.42: ~3.3x
Peer P/NAV Comparison
| Company | P/NAV | Stage | Notes |
|---|---|---|---|
| Cameco (CCJ) | ~3.5-4x | Producing | World-class Tier-1 assets |
| NexGen (NXE) | ~2.5x | Pre-production | World's highest-grade undeveloped deposit |
| UEC | ~3.3x | Early production | Largest U.S. licensed capacity |
| Denison (DNN) | ~2.0x | Pre-production | Smaller, less licensed |
UEC's P/NAV of 3.3x is reasonable for its production stage and asset quality. Not screaming cheap, but not egregiously expensive vs. peers. The premium over NAV reflects production optionality and U.S.-domestic policy premium.
EV/Licensed Capacity Analysis
- EV = $4.6B market cap - $488M cash = ~$4.1B enterprise value
- Licensed capacity: 12M lbs/year
- EV per lb of licensed capacity: ~$342/lb
- Comparison: CCJ's EV/capacity at comparable metric is ~$500-600/lb for premium assets
- UEC's capacity premium is actually lower than CCJ on an EV/capacity basis → suggests capacity is undervalued if the company can execute the ramp
Uranium Price Sensitivity (At Full Production ~2-3M lbs/year, 2028E)
| Uranium Spot | Revenue (est.) | Gross Profit (~$47 margin) | Implied FCF | Multiple needed for $9.42 |
|---|---|---|---|---|
| $70/lb | $210M | ~$93M | ~$50M | ~90x P/FCF → overvalued |
| $86/lb | $258M | ~$141M | ~$90M | ~50x P/FCF → very stretched |
| $100/lb | $300M | ~$183M | ~$130M | ~35x P/FCF → stretched but defensible |
| $120/lb | $360M | ~$243M | ~$185M | ~25x P/FCF → reasonable for a growing miner |
Conclusion: At current uranium prices ($86/lb), UEC's valuation only makes sense if you believe (a) production will ramp materially by 2027-2028 AND (b) uranium spot stays above $80/lb. If uranium falls to $70/lb, the equity would reprice significantly toward $5-7.
Fair Value Range
| Scenario | Uranium Spot | Production by FY2028 | UEC Fair Value |
|---|---|---|---|
| Bear | $60-70/lb | <500K lbs/year | $4-7/share |
| Base | $80-90/lb | 1-2M lbs/year | $10-15/share |
| Bull | $100-120/lb | 3-5M lbs/year + UR&C | $18-28/share |
Current price ($9.42) is at the low end of base case — marginally attractive for a believer in sustained uranium prices, but not a wide-margin-of-safety buy.
Phase 3 — Tension / Debate
Tension identified: Fundamentals (bearish) vs. Moat + Sentiment (bullish)
Fundamentals Analyst: "This company has burned $243M in cash over 4 fiscal years, raised $699M in dilutive equity, produced trivially small volumes of uranium, and posts deeper losses each year. Current production of ~32K lbs/quarter is economically insignificant at any sane institutional scale. At $4.6B market cap, you're paying ~$35,000 per pound of annual production. This fails every screen."
Moat/Valuation rebuttal: "Every metric you cited is expected and appropriate for a development-stage resource company at this phase. The relevant question isn't current cash flow — it's: does the asset base justify the market cap? $794M in liquid assets + $127M uranium inventory + $800M in licensed mineral properties = $1.7B in tangible book. The 3.3x P/NAV premium is the market pricing 12M lbs/year of future production optionality. CCJ traded at similar or higher multiples during its development phase and returned 10x+ to investors who held through the ramp. The permitting moat is durable. The policy tailwinds are concrete."
Fundamentals Analyst rebuttal (revised): "Agreed the asset value is real. My concern is the dilution trajectory. If they issue 15% new shares per year for 5 more years, per-share NAV barely grows even if uranium prices stay firm. The denominator is expanding as fast as the assets. Management needs to demonstrate production ramp by FY2027 without additional equity raises — that's the real test."
Manager synthesis: Both views are partially right. The asset is real. The dilution is real. The key question for prospective buyers is: can UEC ramp production faster than it dilutes? Q3 FY2026 provides the first hard evidence that the answer might be yes — Burke Hollow just started, Christensen Ranch is expanding aggressively, and with $794M in liquid assets, there is no reason to issue more equity near-term. If Q4 FY2026 and Q1 FY2027 show meaningful production increases without equity issuance, the thesis strengthens substantially.
Phase 4 — Final Verdict
Manager's Weighted Verdict
Rating: [6.5/10] — Speculative Buy
UEC is not a value stock by any conventional measure. It is a resource option — a bet that: 1. Uranium prices remain structurally elevated ($80-100+/lb) through the late 2020s 2. UEC successfully ramps production from ~130K lbs/year to 1-3M lbs/year by FY2027-2028 3. The vertical integration thesis (UR&C conversion) adds sustained competitive advantage by the early 2030s 4. U.S. policy support (Section 232, DOE 3×33) creates durable domestic pricing premiums
The evidence supporting this bet: - Uranium demand structural: AI data centers + nuclear renaissance + utility under-contracting (116M lbs secured in 2025 vs. 150M lb replacement need annually) - UEC has the assets: largest licensed U.S. ISR capacity, zero debt, $794M liquid - Production inflection: Burke Hollow commencement is a genuine milestone, not hype - Analyst consensus overwhelmingly positive, price correction appears sentiment-driven
The risks: - Dilution: Has been severe; watch shares outstanding trajectory every quarter - Uranium price: Only marginally accretive at $86/lb at current production scale; needs $90-100+ to make the valuation comfortable - Timeline: Production ramp is a 5-7 year story, not a 12-month story - Policy: Section 232 can be undone
A portfolio-specific passage was removed from the public build.
Entry zone: $8.50–10.50 (current price is in zone) Strong buy: $7.00–8.50 (add aggressively if uranium spot retreats to $75-80 territory and fundamentals intact) Trim: $15.00+ as production volumes and uranium spot confirm Thesis break: (1) Uranium spot below $65 for 2 consecutive quarters, OR (2) Production fails to reach 500K lbs/year by end of FY2027, OR (3) Equity raise above $150M without corresponding major asset acquisition
Suggested position size: 2-3% of portfolio (speculative). Not a core hold. Can be paired with a trim/exit of SMR position to fund — the nuclear exposure is net-improved (UEC has real assets; SMR is a 2033 revenue story with class action overhang).
Offer to add to Watchlist: Yes — conviction [6.5], Energy/Nuclear sector. See below for recommended Watchlist entry.
Key Metrics Summary Table
| Category | Metric | Value | Signal |
|---|---|---|---|
| Price | Current | ~$9.42 | Down 54% from 52wk high |
| Price | 52wk Range | $5.90–$20.34 | Near lower-mid range |
| Size | Market Cap | ~$4.6B | Mid-cap |
| Balance Sheet | Total Financial Debt | $0 | 🟢 Exceptional |
| Balance Sheet | Liquid Assets (Q3 FY2026) | $794M | 🟢 Fortress |
| Balance Sheet | Cash/share | ~$1.62 | 17% of stock price |
| Inventory | Uranium Held | 1.456M lbs | $127M @ $86/lb |
| Production | Q3 FY2026 Run-rate | ~130K lbs/year | 🔴 Very early stage |
| Production | Cost/lb (cumulative) | $39.30 | 🟢 vs. $86 spot |
| Production | Cost/lb (Q3 all-in) | $54.61 | 🟡 Early-stage inflation |
| Capacity | Licensed ISR capacity | 12M lbs/year | Strategic asset |
| Dilution | Shares (FY2022→now) | +69% | 🔴 Significant |
| Analysts | Consensus | 8B / 2SB / 1H | 🟢 Overwhelmingly bullish |
| Valuation | P/NAV | ~3.3x | 🟡 Fair vs. peers |
| Moat | Evergreen Rating | 7/10 | Permitting + ISR + policy |
Recommended Watchlist Entry
- **UEC** — [6.5] — Uranium Energy Corp — **WATCH** | Largest licensed U.S. ISR uranium capacity (12M lbs/yr), $794M liquid assets, zero debt. Burke Hollow commenced (first greenfield ISR in 10+ yrs). UR&C conversion facility NRC docket received. Down 54% from Jan 2026 highs. Entry zone: $8.50–10.50. Strong buy: $7–8.50. Thesis break: spot <$65 for 2 qtrs OR production <500K lbs by FY2027 end. Pairs with LEU for mine→enrichment chain. *Analyzed 2026-06-10.*
Sources: Yahoo Finance MCP (financials, historical prices, analyst consensus), PR Newswire Q3 FY2026 earnings release, SEC EDGAR filings (DEF 14A, 10-Q), Sprott Uranium Insights, Investing News Network, Simply Wall St, Briefglance, PortersFiveForces analysis, Congress.net (BWXT), MarketWise nuclear sector overview.